| 发明名称 |
UTILIZATION OF RALOXIFENE AND THE SALTS THEREOF FOR PREVENTING BREAST CANCER |
| 摘要 |
<p>The invention relates to the utilization of the general formula (I) and the pharmaceutically acceptable salts thereof, for preparing an oral medicine, administered in a dose ranging from 55 to 65 mg/ per day for preventing and reducing the probability of exposure or development of estrogen-dependent breast carcinoma in postmenopausal women.</p> |
| 申请公布号 |
RO120813(B1) |
申请公布日期 |
2006.08.30 |
| 申请号 |
RO19990000482 |
申请日期 |
1997.10.29 |
| 申请人 |
ELI LILLY AND COMPANY |
发明人 |
COHEN FREDRIC J.;ECKERT ROBERT S.;GLUSMAN JOAN E.;KNICKERBOCKER RONALD K.;NICKELSEN NIKOLAUS T.;SCOTT TERI J. |
| 分类号 |
A61K9/00;C07D333/56;A61K9/14;A61K9/20;A61K31/38;A61K31/381;A61K31/445;A61K31/4535;A61P5/32;A61P35/00;A61P43/00 |
主分类号 |
A61K9/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
